- Home
- TGNA vs ACLX Comparison
TGNA vs ACLX Comparison
Compare TGNA & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGNA
- ACLX
- Stock Information
- Founded
- TGNA 1906
- ACLX 2015
- Country
- TGNA United States
- ACLX United States
- Employees
- TGNA N/A
- ACLX N/A
- Industry
- TGNA Broadcasting
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- TGNA Industrials
- ACLX Health Care
- Exchange
- TGNA Nasdaq
- ACLX Nasdaq
- Market Cap
- TGNA 2.8B
- ACLX 3.3B
- IPO Year
- TGNA N/A
- ACLX 2022
- Fundamental
- Price
- TGNA $17.09
- ACLX $62.59
- Analyst Decision
- TGNA Strong Buy
- ACLX Strong Buy
- Analyst Count
- TGNA 4
- ACLX 13
- Target Price
- TGNA $21.75
- ACLX $110.82
- AVG Volume (30 Days)
- TGNA 2.2M
- ACLX 641.0K
- Earning Date
- TGNA 05-08-2025
- ACLX 05-08-2025
- Dividend Yield
- TGNA 2.93%
- ACLX N/A
- EPS Growth
- TGNA 54.83
- ACLX N/A
- EPS
- TGNA 3.53
- ACLX N/A
- Revenue
- TGNA $3,101,971,000.00
- ACLX $107,936,000.00
- Revenue This Year
- TGNA N/A
- ACLX N/A
- Revenue Next Year
- TGNA $12.27
- ACLX $107.10
- P/E Ratio
- TGNA $4.84
- ACLX N/A
- Revenue Growth
- TGNA 6.56
- ACLX N/A
- 52 Week Low
- TGNA $12.35
- ACLX $47.88
- 52 Week High
- TGNA $19.62
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- TGNA 39.32
- ACLX 41.70
- Support Level
- TGNA $18.27
- ACLX $59.45
- Resistance Level
- TGNA $19.00
- ACLX $67.34
- Average True Range (ATR)
- TGNA 0.53
- ACLX 3.65
- MACD
- TGNA -0.06
- ACLX -0.98
- Stochastic Oscillator
- TGNA 0.49
- ACLX 23.26
About TGNA TEGNA Inc
Tegna Inc is a media company with a portfolio of broadcast stations and digital sites. The firm has television stations and radio stations in approximately U.S. markets. The company owns multicast networks of True Crime Network, Twist, and Quest. Each television station also has a robust digital presence across online, mobile, connected television, and social platforms, reaching consumers on all devices and platforms used to consume news content. It generates key revenue from advertising and marketing services, subscriptions, political advertising, and other services.
About ACLX Arcellx Inc.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.